arrow
W

Wouter B. Nagengast

university medical center groningen
H指数:36
被引数:5,496

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A chemiluminescence assay targeting granzyme A activity for monitoring inflammatory bowel disease

靶向granzyme A活性的化学发光检测法用于监测炎症性肠病

2026-01-130
PRE
Tangential flow filtration as a novel approach for fluorescent tracer purification and production up-scaling: cetuximab-800CW and ustekinumab-800CW as a proof-of-concept

切向流过滤作为一种荧光示踪剂纯化和生产规模放大的新方法:西妥昔单抗-800CW和乌司奴单抗-800CW作为概念验证

mAbs
IF7.3
2026-01-010
OA
Development of Clinical-Grade Durvalumab-680LT and Nivolumab-800CW for Multispectral Fluorescent Imaging of the PD-1/PD-L1 Axis of the Immune Checkpoint Pathway

开发临床级Durvalumab-680LT和Nivolumab-800CW用于免疫检查点通路PD-1/PD-L1轴的多光谱荧光成像

2025-10-070
OAAI
Natural course of high-grade dysplasia in Barrett’s esophagus: a scoping review and case series

Barrett食管高级别异型的自然病程:一项范围综述和病例系列

2025-02-190
PREAI
Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial]
2024-10-110
OAAI
Computer-aided diagnosis improves characterization of Barrett's neoplasia by general endoscopists (with video)
2024-10-011
OAAI
The Japanese Esophageal Society classification for prediction of superficial esophageal squamous cell neoplasia invasion depth: Validation in a Western population
2024-06-201
OAAI
Incidence and Prediction of Unrelated Mortality After Successful Endoscopic Eradication Therapy for Barrett's Neoplasia
2024-06-011
OA
Vertical tumor-positive resection margins and the risk of residual neoplasia after endoscopic resection of Barrett's neoplasia: a nationwide cohort with pathology reassessment
ENDOSCOPY
IF12.8
2024-04-052
OAAI
Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial
2024-04-0110
OA